announcement today about FDA clearance for use in diabetic ulcers ect.
thinking to myself
aroa still a biological product and Novosorb synthetic.
but why hasnt PNV commented or made any specific moves to market Novosorb in this space.
Aroa value the TAM for it as 1b+ in US alone.
does anyone know of any case studies or comments from management Around use to novosorb in chronic wounds with healing compromised by disease (diabetes)
cheers
- Forums
- ASX - By Stock
- PNV
- Aroa Discussion
Aroa Discussion
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.46 |
Change
-0.060(2.38%) |
Mkt cap ! $1.706B |
Open | High | Low | Value | Volume |
$2.49 | $2.50 | $2.46 | $835.4K | 336.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 50082 | $2.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.47 | 11421 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 49161 | 2.460 |
19 | 216799 | 2.450 |
11 | 64875 | 2.440 |
10 | 28298 | 2.430 |
7 | 192343 | 2.420 |
Price($) | Vol. | No. |
---|---|---|
2.470 | 24397 | 15 |
2.480 | 36270 | 12 |
2.490 | 35684 | 14 |
2.500 | 38303 | 16 |
2.510 | 64923 | 15 |
Last trade - 13.23pm 04/10/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |